<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Klumpen L</submitter><funding>Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)</funding><funding>Deutsche Forschungsgemeinschaft (German Research Foundation)</funding><pagination>598</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12808737</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(1)</volume><pubmed_abstract>Oats have various positive effects on human health, but the underlying mechanisms are not fully understood. To identify oat-microbiome-host interactions contributing to metabolic improvements, we conducted two randomized controlled dietary interventions in parallel-design in individuals with metabolic syndrome, comparing a short-term, high-dose and a six-week, moderate oat intake with respective controls (DRKS00022169). Both oat diets lead to an increase in plasma ferulic acid (0.64 [0.26, 1.02], P = 0.002; 0.55 [0.21, 0.89], P = 0.003), while the high-dose oat-diet also increased dihydroferulic acid (1.23 [0.44, 2.01], P = 0.003). Here we show that microbial phenolic metabolites are driving factors for the cholesterol-lowering effect of oats, which might be of relevance since short-term, </pubmed_abstract><journal>Nature communications</journal><pubmed_title>Cholesterol-lowering effects of oats induced by microbially produced phenolic metabolites in metabolic syndrome: a randomized controlled trial.</pubmed_title><pmcid>PMC12808737</pmcid><funding_grant_id>432325352 - SFB 1454, EXC 2151-390873048</funding_grant_id><funding_grant_id>432325352 - SFB 1454</funding_grant_id><funding_grant_id>01EA1707</funding_grant_id><pubmed_authors>Wiemann V</pubmed_authors><pubmed_authors>Hasenauer J</pubmed_authors><pubmed_authors>Stoffel-Wagner B</pubmed_authors><pubmed_authors>Burgdorf S</pubmed_authors><pubmed_authors>Schlautmann L</pubmed_authors><pubmed_authors>Seel W</pubmed_authors><pubmed_authors>Klumpen L</pubmed_authors><pubmed_authors>Coenen M</pubmed_authors><pubmed_authors>Thiele C</pubmed_authors><pubmed_authors>Mantri A</pubmed_authors><pubmed_authors>Stehle P</pubmed_authors><pubmed_authors>Philipps M</pubmed_authors><pubmed_authors>Weinhold L</pubmed_authors><pubmed_authors>Fließwasser T</pubmed_authors><pubmed_authors>Yaghmour MH</pubmed_authors><pubmed_authors>Simon MC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cholesterol-lowering effects of oats induced by microbially produced phenolic metabolites in metabolic syndrome: a randomized controlled trial.</name><description>Oats have various positive effects on human health, but the underlying mechanisms are not fully understood. To identify oat-microbiome-host interactions contributing to metabolic improvements, we conducted two randomized controlled dietary interventions in parallel-design in individuals with metabolic syndrome, comparing a short-term, high-dose and a six-week, moderate oat intake with respective controls (DRKS00022169). Both oat diets lead to an increase in plasma ferulic acid (0.64 [0.26, 1.02], P = 0.002; 0.55 [0.21, 0.89], P = 0.003), while the high-dose oat-diet also increased dihydroferulic acid (1.23 [0.44, 2.01], P = 0.003). Here we show that microbial phenolic metabolites are driving factors for the cholesterol-lowering effect of oats, which might be of relevance since short-term, </description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-06-06T15:40:28.81Z</modification><creation>2026-06-02T03:09:17.457Z</creation></dates><accession>S-EPMC12808737</accession><cross_references><pubmed>41535271</pubmed><doi>10.1038/s41467-026-68303-9</doi></cross_references></HashMap>